Lsl Pharma Group Inc (LSL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 7,576 | 7,218 | 6,625 | 5,385 | 4,009 |
| Cost of Goods | 5,245 | 5,157 | 4,519 | 3,913 | 2,815 |
| Gross Profit | 2,331 | 2,061 | 2,106 | 1,472 | 1,194 |
| Operating Expenses | 1,937 | 1,757 | 1,673 | 1,256 | 1,108 |
| Operating Income | 394 | 304 | 433 | 216 | 86 |
| Interest Expense | 758 | 611 | 520 | 517 | 401 |
| Other Income | -816 | -82 | -68 | 4,850 | -71 |
| Pre-tax Income | -1,180 | -389 | -155 | 4,549 | -386 |
| Net Income Continuous | -1,180 | -389 | -155 | 4,499 | -386 |
| Net Income | $-1,180 | $-389 | $-155 | $4,499 | $-386 |
| EPS Basic Total Ops | -0.01 | 0.00 | 0.00 | 0.04 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | 0.00 | 0.04 | 0.00 |
| EPS Diluted Total Ops | -0.01 | 0.00 | 0.00 | 0.04 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | 0.00 | 0.04 | 0.00 |
| EBITDA(a) | $184 | $929 | $836 | $5,541 | $369 |